Intel Mozilla and others announce open alliance for Open COVID Pledge Technology

To work together to combat the epidemic crisis caused by the new coronavirus pandemic, Intel, Mozilla, Creative Commons and others have announced their participation in the Open COVID Pledge Alliance. As the name suggests, the organization aims to bring together and open up the intellectual property rights of businesses to promote the development of COVID-19 prevention and treatment programs, and the free licensing will last until one year after the World Health Organization declares a new coronavirus pandemic.

Intel Mozilla and others announce open alliance for Open COVID Pledge Technology

Interested businesses, institutions, and schools can use the intellectual property rights of members of the organization to develop technologies for COVID-19 diagnosis, prevention, or treatment during the neo-coronavirus pandemic, subject to open COVID licenses.

Mark Lemley, director of the Stanford University’s Legal, Scientific And Technology Program, says:

The project aims to prevent researchers and entrepreneurs from being prosecuted for tools created during special periods that benefit society.

Once the epidemic is brought under control, all parties can still work together to propose commercially reasonable and feasible licensing terms.

At the time of writing, Open COVID Pledge has welcomed members of the DLA Piper, Unified Patents, Intellectual Property Creative Lab, The Fabricatorz Foundation, the University of Basic Medicine, the S.J. Quinney School of Law at the University of Utah, and the Information And Intellectual Property Program at washington Law School, U.S. University.

It hopes to create a framework that allows experts to collaborate to develop diagnostic tools, treatment and prevention solutions, and even to stop the spread of COVID-19 with vaccines.

Finally, Intel announced separately this morning that it will allocate $50 million in funding and resources to help with research related to the fight against the new coronavirus.